Manufacturer:
Sanofi
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis
Conditions:
- Hyperphosphatemia
- Chronic Kidney Disease
Therapeutic Area:
- Endocrinology
- Nephrology